Langconoy, Wilfredo L.
HRN: 21-51-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/30/2022
07/07/2022
IVTT
750mg
Q24
Increasing WBC Trend; Pustular Discharges; Pulmonary Infiltrates
Waiting Final Action
Indication: Empirical Escalation Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes